Company Enlivex Therapeutics Ltd. Deutsche Boerse AG

Equities

1BT

IL0011319527

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG 02:02:22 2024-06-21 am EDT 5-day change 1st Jan Change
1.2 EUR +2.56% Intraday chart for Enlivex Therapeutics Ltd. -11.11% -47.83%

Business Summary

Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Managers

Managers TitleAgeSince
Chief Executive Officer 47 19-11-15
Founder 68 08-12-31
Director of Finance/CFO 47 15-12-31
Chief Operating Officer - -
Human Resources Officer - -
General Counsel - -
Corporate Officer/Principal - 22-02-21
Comptroller/Controller/Auditor 40 17-01-31

Members of the board

Members of the board TitleAgeSince
Chairman 58 13-12-31
Director/Board Member 76 13-12-31
Director/Board Member 52 20-11-30
Director/Board Member 67 22-05-22
Director/Board Member 49 13-12-31
Director/Board Member 53 23-04-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 20,658,555 18,008,736 ( 87.17 %) 0 87.17 %

Shareholders

NameEquities%Valuation
Kip Global Pharma Ecosystem Private Equity Fund
6.810 %
1,421,326 6.810 % 2 M €
Shai Novik
3.709 %
774,033 3.709 % 1 M €
242,345 1.161 % 329 589 €
Avri Havron
0.8602 %
179,540 0.8602 % 244 174 €
Morgan Stanley Capital Services LLC
0.3455 %
72,120 0.3455 % 98 083 €
Renaissance Technologies LLC
0.3348 %
69,889 0.3348 % 95 049 €
Susquehanna Securities LLC
0.3255 %
67,943 0.3255 % 92 402 €
Citadel Securities GP LLC
0.2660 %
55,525 0.2660 % 75 514 €
KSM Mutual Funds Ltd.
0.2241 %
46,766 0.2241 % 63 602 €
IBI Mutual Funds Management (1978) Ltd.
0.2000 %
41,750 0.2000 % 56 780 €

Company contact information

Enlivex Therapeutics Ltd.

14 Einstein Street

7403618, Ness Ziona

+

http://www.enlivex.com
address Enlivex Therapeutics Ltd.(1BT)
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. 1BT Stock
  5. Company Enlivex Therapeutics Ltd.